共 50 条
Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway
被引:56
|作者:
Ding, Jieqiong
[1
,2
]
Tang, Qiong
[1
,2
]
Luo, Binhua
[3
]
Zhang, Lijun
[1
]
Lin, Li
[1
]
Han, Lu
[1
]
Hao, Miaomiao
[3
]
Li, Mingyue
[3
]
Yu, Liangzhu
[1
,2
]
Li, Mincai
[1
,2
]
机构:
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Klotho;
Hypertrophy;
Fibrosis;
Transforming growth factor-beta 1;
Angiotensin II;
LEFT-VENTRICULAR HYPERTROPHY;
GROWTH-FACTOR-BETA;
PROGRESSION;
EXPRESSION;
RECEPTORS;
MODEL;
D O I:
10.1016/j.ejphar.2019.172549
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文